Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Public biotech 2010—the numbers

Nature Biotechnology volume 29, pages 585–591 (2011)Cite this article

Subjects

The biotech sector has bounced back, though the figures can be somewhat misleading.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Global biotech industry financing.
Figure 2: Global biotech IPOs.
Figure 3: Public biotech barometers.
Figure 4: Public biotech companies by geographical location.

Acknowledgements

The authors would like to thank C. Dokomajilar, Senior Biotech Analyst, Deloitte Recap and J. Loughmiller, Managing Director, ARC Consulting, Walnut Creek, CA, USA for their help in crafting this article.

Author information

Authors and Affiliations

  1. Brady Huggett is Business Editor, Nature Biotechnology.,

    Brady Huggett

  2. John Hodgson is Editor-at-Large at Nature Biotechnology.,

    John Hodgson

  3. Riku Lähteenmäki is a freelance writer in Turku, Finland.,

    Riku Lähteenmäki

Authors
  1. Brady Huggett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Hodgson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Riku Lähteenmäki
    View author publications

    You can also search for this author in PubMed Google Scholar

Supplementary information

Supplementary Text and Tables

Supplementary Table 1 (XLS 144 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huggett, B., Hodgson, J. & Lähteenmäki, R. Public biotech 2010—the numbers. Nat Biotechnol 29, 585–591 (2011). https://doi.org/10.1038/nbt.1913

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.1913

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research